Prediction of VEGF mRNA antisense oligodeoxynucleotides by RNA structure software and their effects on HL60 and K562 cells
- PMID: 15985377
- DOI: 10.1016/j.cellbi.2005.04.009
Prediction of VEGF mRNA antisense oligodeoxynucleotides by RNA structure software and their effects on HL60 and K562 cells
Abstract
Seven antisense oligodeoxynucleotides were selected using RNA structure 3.7 software and the principle of low overall DeltaG (free energy). Their effects on cell growth, VEGF protein expression and apoptosis in HL60 and K562 leukemic cells were examined, and cell numbers and viability were assessed using trypan blue dye exclusion, MTT, ELISA and flow cytometry. The results showed that six of the seven antisense sequences inhibited the cell growth and down-regulated VEGF protein expression significantly. Endogenous VEGF plays an important role in the proliferation of HL60 and K562 leukemic cells. RNA structure software provides a rapid and efficient way of identifying effective antisense oligodeoxynucleotides.
Similar articles
-
[VEGF antisense oligonucleotide inhibits the expression of vascular endothelial growth factor in human leukemic cell lines].Zhonghua Xue Ye Xue Za Zhi. 2004 Jan;25(1):22-5. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 14990072 Chinese.
-
Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence.Cancer Gene Ther. 2003 Dec;10(12):879-86. doi: 10.1038/sj.cgt.7700645. Cancer Gene Ther. 2003. PMID: 14712314
-
[Effect and mechanism of VEGF antisense phosphorothioate deoxynucleotides on HL-60 leukemic cells].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Oct;12(5):640-3. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004. PMID: 15498126 Chinese.
-
Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides.Biochim Biophys Acta. 1999 Dec 10;1489(1):53-68. doi: 10.1016/s0167-4781(99)00141-4. Biochim Biophys Acta. 1999. PMID: 10806997 Review.
-
Transcriptional regulation of the human proenkephalin gene by conformational switching: implications for decoy design.Antisense Nucleic Acid Drug Dev. 1998 Apr;8(2):159-65. doi: 10.1089/oli.1.1998.8.159. Antisense Nucleic Acid Drug Dev. 1998. PMID: 9593057 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources